National Institute of Allergy and Infectious Diseases; Notice of Closed Meeting, 71660-71661 [2020-24873]
Download as PDF
<![CDATA[
jbell on DSKJLSW7X2PROD with NOTICES
71660
Federal Register / Vol. 85, No. 218 / Tuesday, November 10, 2020 / Notices
New Animal Drugs for Minor Uses and
for Minor Species.’’ Received comments
will be placed in the docket and, except
for those submitted as ‘‘Confidential
Submissions,’’ publicly viewable at
https://www.regulations.gov or at the
Dockets Management Staff between 9
a.m. and 4 p.m., Monday through
Friday, 240–402–7500.
• Confidential Submissions—To
submit a comment with confidential
information that you do not wish to be
made publicly available, submit your
comments only as a written/paper
submission. You should submit two
copies total. One copy will include the
information you claim to be confidential
with a heading or cover note that states
‘‘THIS DOCUMENT CONTAINS
CONFIDENTIAL INFORMATION.’’ The
Agency will review this copy, including
the claimed confidential information, in
its consideration of comments. The
second copy, which will have the
claimed confidential information
redacted/blacked out, will be available
for public viewing and posted on
https://www.regulations.gov. Submit
both copies to the Dockets Management
Staff. If you do not wish your name and
contact information to be made publicly
available, you can provide this
information on the cover sheet and not
in the body of your comments and you
must identify this information as
‘‘confidential.’’ Any information marked
as ‘‘confidential’’ will not be disclosed
except in accordance with 21 CFR 10.20
and other applicable disclosure law. For
more information about FDA’s posting
of comments to public dockets, see 80
FR 56469, September 18, 2015, or access
the information at: https://
www.govinfo.gov/content/pkg/FR-201509-18/pdf/2015-23389.pdf.
Docket: For access to the docket to
read background documents or the
electronic and written/paper comments
received, go to https://
www.regulations.gov and insert the
docket number, found in brackets in the
heading of this document, into the
‘‘Search’’ box and follow the prompts
and/or go to the Dockets Management
Staff, 5630 Fishers Lane, Rm. 1061,
Rockville, MD 20852, 240–402–7500.
FOR FURTHER INFORMATION CONTACT:
Margaret Oeller, Center for Veterinary
Medicine (HFV–50), Food and Drug
Administration, 7500 Standish Pl.,
Rockville, MD 20855, 240–402–0566,
margaret.oeller@fda.hhs.gov.
SUPPLEMENTARY INFORMATION: In the
Federal Register of July 15, 2020, FDA
published a notice announcing the
availability of draft GFI #61 entitled
‘‘Special Considerations, Incentives, and
Programs to Support the Approval of
VerDate Sep<11>2014
17:21 Nov 09, 2020
Jkt 253001
New Animal Drugs for Minor Uses and
for Minor Species’’ with a 120-day
comment period.
Interested persons were originally
given until November 12, 2020, to
comment on the draft guidance. The
Agency received a request to allow
interested persons additional time to
comment. The request conveyed
concern that the initial 120-day
comment period did not allow sufficient
time to develop a comprehensive
response. FDA believes that an
extension of 60 days allows adequate
time for interested persons to submit
comments.
Dated: November 5, 2020.
Lauren K. Roth,
Acting Principal Associate Commissioner for
Policy.
[FR Doc. 2020–24970 Filed 11–9–20; 8:45 am]
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
Eunice Kennedy Shriver National
Institute of Child Health & Human
Development; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of a
meeting of the Board of Scientific
Counselors, NICHD.
The meeting will be closed to the
public as indicated below in accordance
with the provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended for the review, discussion,
and evaluation of individual intramural
programs and projects conducted by the
EUNICE KENNEDY SHRIVER
NATIONAL INSTITUTE OF CHILD
HEALTH & HUMAN DEVELOPMENT,
including consideration of personnel
qualifications and performance, and the
competence of individual investigators,
the disclosure of which would
constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: Board of Scientific
Counselors, NICHD.
Date: December 4, 2020.
Time: 10:00 a.m. to 4:00 p.m.
Agenda: A report by the Acting Scientific
Director, NICHD, on the status of the NICHD
Division of Intramural Research; current
organizational structure; to review and
evaluate personnel qualifications and
performance, and competence of individual
investigators.
Place: National Institutes of Health, 31
Center Drive, Bethesda, MD 20892 (VideoAssisted Meeting).
Fmt 4703
[FR Doc. 2020–24870 Filed 11–9–20; 8:45 am]
Sfmt 4703
DEPARTMENT OF HEALTH AND
HUMAN SERVICES
National Institutes of Health
National Institutes of Health
Frm 00058
Dated: November 4, 2020.
Ronald J. Livingston, Jr.,
Program Analyst, Office of Federal Advisory
Committee Policy.
BILLING CODE 4140–01–P
BILLING CODE 4164–01–P
PO 00000
Contact Person: Mary C. Dasso, Ph.D.,
Acting Scientific Director, Eunice Kennedy
Shriver National Institute of Child Health and
Human Development, NIH, 9000 Rockville
Pike, Building 31A, Room 2A46, Bethesda,
MD 20892, (301) 594–5984, dassom@
mail.nih.gov.
Information is also available on the
Institute’s/Center’s home page: https://
www.nichd.nih.gov/about/meetings/Pages/
index.aspx, where an agenda and any
additional information for the meeting will
be posted when available.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.865, Research for Mothers
and Children, National Institutes of Health,
HHS)
National Institute of Allergy and
Infectious Diseases; Notice of Closed
Meeting
Pursuant to section 10(d) of the
Federal Advisory Committee Act, as
amended, notice is hereby given of the
following meeting.
The meeting will be closed to the
public in accordance with the
provisions set forth in sections
552b(c)(4) and 552b(c)(6), Title 5 U.S.C.,
as amended. The grant applications and
the discussions could disclose
confidential trade secrets or commercial
property such as patentable material,
and personal information concerning
individuals associated with the grant
applications, the disclosure of which
would constitute a clearly unwarranted
invasion of personal privacy.
Name of Committee: National Institute of
Allergy and Infectious Diseases Special
Emphasis Panel; Emergency Awards: Rapid
Investigation of Severe Acute Respiratory
Syndrome Coronavirus 2 (SARS–CoV–2) and
Coronavirus Disease 2019 (COVID–19).
Date: December 18, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant
applications.
Place: National Institute of Allergy and
Infectious Diseases, National Institutes of
Health, 5601 Fishers Lane, Room 3G53,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Konrad J. Krzewski, Ph.D.,
Scientific Review Officer, Scientific Review
Program, Division of Extramural Activities,
National Institute of Allergy and Infectious
Diseases, National Institutes of Health, 5601
Fishers Lane, Room 3G53, Rockville, MD
E:\FR\FM\10NON1.SGM
10NON1
Federal Register / Vol. 85, No. 218 / Tuesday, November 10, 2020 / Notices
20852, (240) 747–7526, konrad.krzewski@
nih.gov.
(Catalogue of Federal Domestic Assistance
Program Nos. 93.855, Allergy, Immunology,
and Transplantation Research; 93.856,
Microbiology and Infectious Diseases
Research, National Institutes of Health, HHS)
Dated: November 4, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory
Committee Policy.
[FR Doc. 2020–24873 Filed 11–9–20; 8:45 am]
BILLING CODE 4140–01–P
DEPARTMENT OF HOUSING AND
URBAN DEVELOPMENT
[Docket No. FR–6237–N–02]
Notice of a Federal Advisory
Committee Meeting Manufactured
Housing Consensus Committee
Office of the Assistant
Secretary for Housing—Federal Housing
Commissioner, Department of Housing
and Urban Development (HUD).
ACTION: Notice of Federal Advisory
Committee Meetings: Manufactured
Housing Consensus Committee (MHCC).
AGENCY:
This notice sets forth the
schedule and proposed agenda for the
Technical System Subcommittee
teleconference meeting of the MHCC.
The meeting is open to the public. The
agenda for the meeting provides an
opportunity for citizens to comment on
the business before the MHCC
Subcommittee.
DATES: The Technical Systems
Subcommittee meeting will be held on
December 8, 2020, 10:00 a.m. to 4:00
p.m. Eastern Standard Time (EST). The
teleconference number is: 301–715–
8592 or 646–558–8656 and the Meeting
ID is: 96243433408. To access the
webinar, use the following link: https://
zoom.us/j/96243433408.
FOR FURTHER INFORMATION CONTACT:
Teresa B. Payne, Administrator, Office
of Manufactured Housing Programs,
Department of Housing and Urban
Development, 451 7th Street SW, Room
9166, Washington, DC 20410, telephone
202–402–2698 (this is not a toll-free
number). Persons who have difficulty
hearing or speaking may access this
number via TTY by calling the Federal
Relay Service at 800–877–8339 (this is
a toll-free number).
SUPPLEMENTARY INFORMATION: Notice of
these meetings are provided in
accordance with the Federal Advisory
Committee Act, 5 U.S.C. App. 10(a)(2)
through implementing regulations at 41
CFR 102–3.150. The MHCC was
established by the National
jbell on DSKJLSW7X2PROD with NOTICES
SUMMARY:
VerDate Sep<11>2014
17:21 Nov 09, 2020
Jkt 253001
Manufactured Housing Construction
and Safety Standards Act of 1974, 42
U.S.C. 5403(a)(3), as amended by the
Manufactured Housing Improvement
Act of 2000, (Pub. L. 106–569, Sec. 601,
et seq.). According to 42 U.S.C. 5403, as
amended, the purposes of the MHCC are
to:
• Provide periodic recommendations
to the Secretary to adopt, revise, and
interpret the Federal manufactured
housing construction and safety
standards in accordance with this
subsection;
• Provide periodic recommendations
to the Secretary to adopt, revise, and
interpret the procedural and
enforcement regulations, including
regulations specifying the permissible
scope and conduct of monitoring in
accordance with subsection (b); and
• Be organized and carry out its
business in a manner that guarantees a
fair opportunity for the expression and
consideration of various positions and
for public participation.
The MHCC is deemed an advisory
committee not composed of Federal
employees.
Public Comment: Citizens wishing to
make comments on the business of the
MHCC must register in advance by
contacting the Administering
Organization (AO), Home Innovation
Research Labs; Attention: Kevin
Kauffman, 400 Prince Georges Blvd.,
Upper Marlboro, MD 20774, or email to
mhcc@homeinnovation.com, or call
888–602–4663. With advance
registration, members of the public will
have an opportunity to provide written
comments relative to agenda topics for
the Subcommittee’s consideration. All
written comments must be provided to
mhcc@homeinnovation.com. Written
comments must be provided no later
than December 3, 2020. Please note,
written comments submitted will not be
read during the meeting but will be
provided to the Subcommittee members
prior to the meeting. The MHCC will
also provide an opportunity for oral
public comments on specific matters
before the Subcommittee. The total
amount of time for oral comments will
be 30 minutes, in two 15-minute
periods, with each commenter limited
to two minutes to ensure pertinent
Subcommittee business is completed
and all public comments can be
expressed. The Subcommittee will not
respond to individual written or oral
statements; however, it will take all
public comments into account in its
deliberations. The MHCC strives to
accommodate citizen comments to the
extent possible within the time
constraints of the meeting agenda.
PO 00000
Frm 00059
Fmt 4703
Sfmt 4703
71661
Tentative Agenda for Technical
Systems Subcommittee Teleconference
Tuesday, December 8, 2020—10 a.m. to
4 p.m. EST
I. Call to Order—Subcommittee Chair &
Designated Federal Officer (DFO) Roll
Call—AO
II. Opening Remarks—Subcommittee Chair &
DFO
III. Approval of minutes from the October 30,
2019, Technical Systems Subcommittee
Meeting Occurring as Part of the MHCC
Annual Meeting
IV. Public Comment Period—15 minutes
V. Assigned Proposed Change Review
Proposed Changes Log:
• LOG 211, LOG 212, LOG 216, LOG 219,
LOG 222, and LOG 223 (These log items
can be viewed through the following web
address: https://www.hud.gov/sites/
dfiles/images/ProposedChanges202021Cycle.pdf)
VI. Lunch from 12:30 p.m. to 1:30 p.m.
VII. Assigned Proposed Change Review
Continued
VIII. Public Comment Period—15 minutes
IX. Wrap Up—DFO & AO
X. Adjourn
Dana T. Wade,
Assistant Secretary for Housing-Federal
Housing Commissioner.
[FR Doc. 2020–24940 Filed 11–9–20; 8:45 am]
BILLING CODE 4210–67–P
DEPARTMENT OF LABOR
Mine Safety and Health Administration
Petitions for Modification of
Application of Existing Mandatory
Safety Standards
Mine Safety and Health
Administration, Labor.
ACTION: Notice.
AGENCY:
This notice is a summary of
two petitions for modification submitted
to the Mine Safety and Health
Administration (MSHA) by the parties
listed below.
DATES: All comments on the petitions
must be received by MSHA’s Office of
Standards, Regulations, and Variances
on or before December 10, 2020.
ADDRESSES: You may submit your
comments, identified by ‘‘docket
number’’ on the subject line, by any of
the following methods:
1. Electronic Mail: zzMSHAcomments@dol.gov. Include the docket
number of the petition in the subject
line of the message.
2. Facsimile: 202–693–9441.
3. Regular Mail or Hand Delivery:
MSHA, Office of Standards,
Regulations, and Variances, 201 12th
Street South, Suite 4E401, Arlington,
Virginia 22202–5452, Attention: Roslyn
SUMMARY:
E:\FR\FM\10NON1.SGM
10NON1
]]>Agencies
[Federal Register Volume 85, Number 218 (Tuesday, November 10, 2020)]
[Notices]
[Pages 71660-71661]
From the Federal Register Online via the Government Publishing Office [www.gpo.gov]
[FR Doc No: 2020-24873]
-----------------------------------------------------------------------
DEPARTMENT OF HEALTH AND HUMAN SERVICES
National Institutes of Health
National Institute of Allergy and Infectious Diseases; Notice of
Closed Meeting
Pursuant to section 10(d) of the Federal Advisory Committee Act, as
amended, notice is hereby given of the following meeting.
The meeting will be closed to the public in accordance with the
provisions set forth in sections 552b(c)(4) and 552b(c)(6), Title 5
U.S.C., as amended. The grant applications and the discussions could
disclose confidential trade secrets or commercial property such as
patentable material, and personal information concerning individuals
associated with the grant applications, the disclosure of which would
constitute a clearly unwarranted invasion of personal privacy.
Name of Committee: National Institute of Allergy and Infectious
Diseases Special Emphasis Panel; Emergency Awards: Rapid
Investigation of Severe Acute Respiratory Syndrome Coronavirus 2
(SARS-CoV-2) and Coronavirus Disease 2019 (COVID-19).
Date: December 18, 2020.
Time: 11:00 a.m. to 6:00 p.m.
Agenda: To review and evaluate grant applications.
Place: National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G53,
Rockville, MD 20892 (Virtual Meeting).
Contact Person: Konrad J. Krzewski, Ph.D., Scientific Review
Officer, Scientific Review Program, Division of Extramural
Activities, National Institute of Allergy and Infectious Diseases,
National Institutes of Health, 5601 Fishers Lane, Room 3G53,
Rockville, MD
[[Page 71661]]
20852, (240) 747-7526, [email protected].
(Catalogue of Federal Domestic Assistance Program Nos. 93.855,
Allergy, Immunology, and Transplantation Research; 93.856,
Microbiology and Infectious Diseases Research, National Institutes
of Health, HHS)
Dated: November 4, 2020.
Tyeshia M. Roberson,
Program Analyst, Office of Federal Advisory Committee Policy.
[FR Doc. 2020-24873 Filed 11-9-20; 8:45 am]
BILLING CODE 4140-01-P
